Selected research
Industry Research
Alt Protein Industry Research Report 2026
Market perspective
The global Alt Protein market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Alt Protein is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Alt Protein is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Alt Protein is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Alt Protein include Kerry, Cargill, Archer Daniels Midland, Glanbia, CHS, Tereos Syral, CP Kelco, Davisco and Meelunie, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Alt Protein market in terms of revenue (US$ million) and, where applicable, sales volume (k units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Alt Protein Market by Company
Kerry
Cargill
Archer Daniels Midland
Glanbia
CHS
Tereos Syral
CP Kelco
Davisco
Meelunie
DuPont
MGP Ingredient
Taj Agro Product
Glico Nutrition
Alt Protein Segment by Type
Plant-Based
Fungi-Based
Algae-Based
Insect-Based
Others
Alt Protein Segment by Application
Food & Beverage
Healthcare Products
Others
Alt Protein Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Alt Protein market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Alt Protein and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Alt Protein.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Alt Protein manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Alt Protein by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Alt Protein in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Plant-Based
- Fungi-Based
- Algae-Based
- Insect-Based
- Others
Applications
- Food & Beverage
- Healthcare Products
- Others
Companies covered
- Kerry
- Cargill
- Archer Daniels Midland
- Glanbia
- CHS
- Tereos Syral
- CP Kelco
- Davisco
- Meelunie
- DuPont
- MGP Ingredient
- Taj Agro Product
- Glico Nutrition
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Alt Protein Market Size (2021-2032)
- 2.2.2 Global Alt Protein Sales (2021-2032)
- 2.2.3 Global Alt Protein Market Average Price (2021-2032)
- 2.3 Alt Protein by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Plant-Based
- 2.3.3 Fungi-Based
- 2.3.4 Algae-Based
- 2.3.5 Insect-Based
- 2.3.6 Others
- 2.4 Alt Protein by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Food & Beverage
- 2.4.3 Healthcare Products
- 2.4.4 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Alt Protein Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Alt Protein Sales (k units) of Manufacturers (2021-2026)
- 3.3 Global Alt Protein Revenue of Manufacturers (2021-2026)
- 3.4 Global Alt Protein Average Price by Manufacturers (2021-2026)
- 3.5 Global Alt Protein Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Alt Protein, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Alt Protein, Product Type & Application
- 3.8 Global Manufacturers of Alt Protein, Established Date
- 3.9 Global Alt Protein Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Kerry
- 4.1.1 Kerry Company Information
- 4.1.2 Kerry Business Overview
- 4.1.3 Kerry Alt Protein Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Kerry Alt Protein Product Portfolio
- 4.1.5 Kerry Recent Developments
- 4.2 Cargill
- 4.2.1 Cargill Company Information
- 4.2.2 Cargill Business Overview
- 4.2.3 Cargill Alt Protein Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Cargill Alt Protein Product Portfolio
- 4.2.5 Cargill Recent Developments
- 4.3 Archer Daniels Midland
- 4.3.1 Archer Daniels Midland Company Information
- 4.3.2 Archer Daniels Midland Business Overview
- 4.3.3 Archer Daniels Midland Alt Protein Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Archer Daniels Midland Alt Protein Product Portfolio
- 4.3.5 Archer Daniels Midland Recent Developments
- 4.4 Glanbia
- 4.4.1 Glanbia Company Information
- 4.4.2 Glanbia Business Overview
- 4.4.3 Glanbia Alt Protein Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Glanbia Alt Protein Product Portfolio
- 4.4.5 Glanbia Recent Developments
- 4.5 CHS
- 4.5.1 CHS Company Information
- 4.5.2 CHS Business Overview
- 4.5.3 CHS Alt Protein Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 CHS Alt Protein Product Portfolio
- 4.5.5 CHS Recent Developments
- 4.6 Tereos Syral
- 4.6.1 Tereos Syral Company Information
- 4.6.2 Tereos Syral Business Overview
- 4.6.3 Tereos Syral Alt Protein Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Tereos Syral Alt Protein Product Portfolio
- 4.6.5 Tereos Syral Recent Developments
- 4.7 CP Kelco
- 4.7.1 CP Kelco Company Information
- 4.7.2 CP Kelco Business Overview
- 4.7.3 CP Kelco Alt Protein Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 CP Kelco Alt Protein Product Portfolio
- 4.7.5 CP Kelco Recent Developments
- 4.8 Davisco
- 4.8.1 Davisco Company Information
- 4.8.2 Davisco Business Overview
- 4.8.3 Davisco Alt Protein Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Davisco Alt Protein Product Portfolio
- 4.8.5 Davisco Recent Developments
- 4.9 Meelunie
- 4.9.1 Meelunie Company Information
- 4.9.2 Meelunie Business Overview
- 4.9.3 Meelunie Alt Protein Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Meelunie Alt Protein Product Portfolio
- 4.9.5 Meelunie Recent Developments
- 4.10 DuPont
- 4.10.1 DuPont Company Information
- 4.10.2 DuPont Business Overview
- 4.10.3 DuPont Alt Protein Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 DuPont Alt Protein Product Portfolio
- 4.10.5 DuPont Recent Developments
- 4.11 MGP Ingredient
- 4.11.1 MGP Ingredient Company Information
- 4.11.2 MGP Ingredient Business Overview
- 4.11.3 MGP Ingredient Alt Protein Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 MGP Ingredient Alt Protein Product Portfolio
- 4.11.5 MGP Ingredient Recent Developments
- 4.12 Taj Agro Product
- 4.12.1 Taj Agro Product Company Information
- 4.12.2 Taj Agro Product Business Overview
- 4.12.3 Taj Agro Product Alt Protein Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Taj Agro Product Alt Protein Product Portfolio
- 4.12.5 Taj Agro Product Recent Developments
- 4.13 Glico Nutrition
- 4.13.1 Glico Nutrition Company Information
- 4.13.2 Glico Nutrition Business Overview
- 4.13.3 Glico Nutrition Alt Protein Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 Glico Nutrition Alt Protein Product Portfolio
- 4.13.5 Glico Nutrition Recent Developments
5 Global Alt Protein Market Scenario by Region
- 5.1 Global Alt Protein Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Alt Protein Sales by Region: 2021-2032
- 5.2.1 Global Alt Protein Sales by Region: 2021-2026
- 5.2.2 Global Alt Protein Sales by Region: 2027-2032
- 5.3 Global Alt Protein Revenue by Region: 2021-2032
- 5.3.1 Global Alt Protein Revenue by Region: 2021-2026
- 5.3.2 Global Alt Protein Revenue by Region: 2027-2032
- 5.4 North America Alt Protein Market Facts & Figures by Country
- 5.4.1 North America Alt Protein Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Alt Protein Sales by Country (2021-2032)
- 5.4.3 North America Alt Protein Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Alt Protein Market Facts & Figures by Country
- 5.5.1 Europe Alt Protein Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Alt Protein Sales by Country (2021-2032)
- 5.5.3 Europe Alt Protein Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Alt Protein Market Facts & Figures by Country
- 5.6.1 Asia Pacific Alt Protein Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Alt Protein Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Alt Protein Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Alt Protein Market Facts & Figures by Country
- 5.7.1 South America Alt Protein Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Alt Protein Sales by Country (2021-2032)
- 5.7.3 South America Alt Protein Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Alt Protein Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Alt Protein Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Alt Protein Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Alt Protein Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Alt Protein Sales by Type (2021-2032)
- 6.1.1 Global Alt Protein Sales by Type (2021-2032) & (k units)
- 6.1.2 Global Alt Protein Sales Market Share by Type (2021-2032)
- 6.2 Global Alt Protein Revenue by Type (2021-2032)
- 6.2.1 Global Alt Protein Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Alt Protein Revenue Market Share by Type (2021-2032)
- 6.3 Global Alt Protein Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Alt Protein Sales by Application (2021-2032)
- 7.1.1 Global Alt Protein Sales by Application (2021-2032) & (k units)
- 7.1.2 Global Alt Protein Sales Market Share by Application (2021-2032)
- 7.2 Global Alt Protein Revenue by Application (2021-2032)
- 7.2.1 Global Alt Protein Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Alt Protein Revenue Market Share by Application (2021-2032)
- 7.3 Global Alt Protein Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Alt Protein Value Chain Analysis
- 8.1.1 Alt Protein Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Alt Protein Production Mode & Process
- 8.2 Alt Protein Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Alt Protein Distributors
- 8.2.3 Alt Protein Customers
9 Global Alt Protein Analyzing Market Dynamics
- 9.1 Alt Protein Industry Trends
- 9.2 Alt Protein Industry Drivers
- 9.3 Alt Protein Industry Opportunities and Challenges
- 9.4 Alt Protein Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst